GPT and Hepatic fibrosis: Fourth, experimental studies demonstrate that A. muciniphila administration protects against various hepatotoxic insults by reducing serum ALT/AST levels (30–50% reduction), attenuating oxidative stress through enhanced glutathione activity, and improving liver fibrosis markers [29,36].